Status:
ACTIVE_NOT_RECRUITING
Life After Transient Ischemic Attack
Lead Sponsor:
Aalborg University Hospital
Collaborating Sponsors:
Aalborg University
Conditions:
Transient Ischemic Attack
Quality of Life
Eligibility:
All Genders
18+ years
Brief Summary
Background: Transient ischemic attack (TIA) is defined as acute neurological symptoms of vascular origin, which resolves completely within 24 hours. However, emerging evidence indicates that up to 1/3...
Detailed Description
Background: In Denmark approximately 4.000 patients every year are diagnosed with Transient Ischemic Attack (TIA). In Denmark the time-based definition of TIA is used and based on a clinical assessme...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Diagnosis of TIA (ICD-10 code DG45, except DG45.3 Amaurosis fugax and DG45.4 Global Transient Amnesia) and for a) accumulated TIA (\>1 event within the last 30 days): contact to the healthcare system within 30 days from symptom onset, b) not-accumulated TIA: contact to the healthcare system within 7 days from symptom onset. (as defined in the Danish Stroke Registry)
- Minimum 18 years of age
- Availability for follow-up during the study period
- Able to read and understand Danish
- Able to fill out questionnaires (assessed by the associated healthcare professional)
- Not included in any other research projects
Exclusion
Key Trial Info
Start Date :
February 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2025
Estimated Enrollment :
355 Patients enrolled
Trial Details
Trial ID
NCT05234528
Start Date
February 1 2022
End Date
March 1 2025
Last Update
May 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aalborg University Hospital
Aalborg, Denmark, 9000